speb/financial-data huggingface dataset:
MYSE income_statement (annual, 2023-12-31) — Research And Development: 1351415.00
MYSE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -42737.00
MYSE balance_sheet (annual, 2023-12-31) — Retained Earnings: -48134088.00
MYSE income_statement (annual, 2023-12-31) — Salaries And Wages: 4760180.00
MYSE cash_flow (annual, 2023-12-31) — Sale Of Business: 64538.00
MYSE cash_flow (annual, 2023-12-31) — Sale Of Intangibles: 0.00
MYSE cash_flow (annual, 2023-12-31) — Sale Of Investment: 14745000.00
MYSE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 388444.00
MYSE income_statement (annual, 2023-12-31) — Selling General And Administration: 7366236.00
MYSE balance_sheet (annual, 2023-12-31) — Share Issued: 2103321.00
MYSE income_statement (annual, 2023-12-31) — Special Income Charges: -24315.00
MYSE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2254079.00
MYSE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 6099989.00
MYSE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 6099789.00
MYSE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MYSE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
MYSE balance_sheet (annual, 2023-12-31) — Total Assets: 6506543.00
MYSE balance_sheet (annual, 2023-12-31) — Total Capitalization: 6099989.00
MYSE balance_sheet (annual, 2023-12-31) — Total Debt: 83674.00
MYSE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 6099989.00
MYSE income_statement (annual, 2023-12-31) — Total Expenses: 8717651.00
MYSE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 406554.00
MYSE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 130542.00
MYSE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MYSE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -8784031.00
MYSE income_statement (annual, 2023-12-31) — Total Unusual Items: -72089.00
MYSE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -72089.00
MYSE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 66945.00
MYSE balance_sheet (annual, 2023-12-31) — Treasury Stock: 397969.00
MYSE cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 47672.00
MYSE balance_sheet (annual, 2023-12-31) — Working Capital: 5969447.00
MYSE cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
MYSE income_statement (quarterly, 2024-09-30) — Basic Average Shares: 3009329.00
MYSE income_statement (quarterly, 2024-09-30) — Basic EPS: -0.42
MYSE cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
MYSE balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 22851.00
MYSE income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 3009329.00
MYSE income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.42
MYSE cash_flow (quarterly, 2024-09-30) — Effect Of Exchange Rate Changes: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: 0.00
MYSE income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 0.00
MYSE balance_sheet (quarterly, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
MYSE income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 166667.00
MYSE balance_sheet (quarterly, 2024-09-30) — Other Properties: 39218.00
MYSE balance_sheet (quarterly, 2024-09-30) — Preferred Stock Equity: 200.00
MYSE cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
MYSE income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
MYSE cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
MYSE income_statement (annual, 2024-12-31) — +Operating Expense: 3217603.00
MYSE income_statement (annual, 2024-12-31) — +Total Revenue: 436.00
MYSE balance_sheet (annual, 2024-12-31) — Accounts Payable: 603378.00
MYSE balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 603378.00
MYSE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 207.00
MYSE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -265977.00
MYSE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 59649645.00
MYSE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 446670.00
MYSE balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 446670.00
MYSE income_statement (annual, 2024-12-31) — Basic Average Shares: 2958821.00
MYSE income_statement (annual, 2024-12-31) — Basic EPS: -1.43
MYSE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 946408.00
MYSE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 198898.00
MYSE balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 198898.00
MYSE cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Capital Stock: 508.00
MYSE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 766985.00
MYSE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3719497.00
MYSE balance_sheet (annual, 2024-12-31) — Cash Financial: 766985.00
MYSE balance_sheet (quarterly, 2024-12-31) — Cash Financial: 766985.00
MYSE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 2394971.00
MYSE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 2236751.00
MYSE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -4811145.00
MYSE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -83674.00
MYSE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -412207.00
MYSE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 282697.00
MYSE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 4639.00
MYSE cash_flow (annual, 2024-12-31) — Change In Receivables: -24.00
MYSE cash_flow (annual, 2024-12-31) — Change In Working Capital: -208569.00
MYSE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -24.00
MYSE cash_flow (annual, 2024-12-31) — Changes In Cash: -179423.00
MYSE balance_sheet (annual, 2024-12-31) — Common Stock: 308.00
MYSE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 6878736.00
MYSE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1533449.00
MYSE cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
MYSE income_statement (annual, 2024-12-31) — Cost Of Revenue: 1794611.00
MYSE income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 438445.00
MYSE balance_sheet (annual, 2024-12-31) — Current Assets: 4288022.00
MYSE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 88.00
MYSE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 88.00
MYSE balance_sheet (annual, 2024-12-31) — Current Liabilities: 630311.00
MYSE cash_flow (annual, 2024-12-31) — Depreciation: 97106.00
MYSE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 97106.00
MYSE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 97106.00
MYSE income_statement (annual, 2024-12-31) — Diluted Average Shares: 2958821.00
MYSE income_statement (annual, 2024-12-31) — Diluted EPS: -1.43
MYSE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -4239160.00
MYSE income_statement (annual, 2024-12-31) — EBIT: -3217167.00
MYSE income_statement (annual, 2024-12-31) — EBITDA: -3120061.00
MYSE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
MYSE cash_flow (annual, 2024-12-31) — End Cash Position: 766985.00
MYSE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 2394971.00
MYSE cash_flow (annual, 2024-12-31) — Free Cash Flow: -4811145.00
MYSE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
MYSE income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 107.00
MYSE income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 0.00
MYSE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -12965.00
MYSE income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
MYSE income_statement (annual, 2024-12-31) — General And Administrative Expense: 2966773.00
MYSE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1050000.00
MYSE balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 1050000.00
MYSE balance_sheet (annual, 2024-12-31) — Gross PPE: 299413.00
MYSE income_statement (annual, 2024-12-31) — Gross Profit: -1794175.00
MYSE income_statement (quarterly, 2024-12-31) — Gross Profit: -438353.00
MYSE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
MYSE income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
MYSE cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
MYSE income_statement (annual, 2024-12-31) — Interest Income: 268752.00
MYSE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 268752.00
MYSE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Invested Capital: 6878736.00
MYSE cash_flow (annual, 2024-12-31) — Investing Cash Flow: 2236751.00
MYSE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
MYSE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1533449.00
MYSE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Leases: 4350.00
MYSE balance_sheet (quarterly, 2024-12-31) — Leases: 4350.00
MYSE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 96165.00
MYSE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 96165.00
MYSE balance_sheet (annual, 2024-12-31) — Minority Interest: -2137789.00
MYSE income_statement (annual, 2024-12-31) — Minority Interests: 785847.00
MYSE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
MYSE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1533449.00
MYSE cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 12965.00
MYSE cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MYSE income_statement (annual, 2024-12-31) — Net Income: -4239160.00
MYSE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -4239160.00
MYSE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -2948415.00
MYSE income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -2076592.00
MYSE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4239160.00
MYSE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -2162568.00
MYSE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -5025007.00
MYSE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -5025007.00
MYSE income_statement (annual, 2024-12-31) — Net Interest Income: 268752.00
MYSE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 2236751.00
MYSE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MYSE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 268752.00
MYSE balance_sheet (annual, 2024-12-31) — Net PPE: 33436.00
MYSE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
MYSE cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
MYSE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 5828936.00
MYSE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 0.00
MYSE income_statement (annual, 2024-12-31) — Normalized EBITDA: -3120061.00
MYSE income_statement (annual, 2024-12-31) — Normalized Income: -2162568.00
MYSE cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4811145.00
MYSE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 12965.00
MYSE cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
MYSE income_statement (annual, 2024-12-31) — Operating Income: -3217167.00
MYSE income_statement (annual, 2024-12-31) — Operating Revenue: 436.00
MYSE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 3009329.00
MYSE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 26845.00
MYSE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 26845.00
MYSE income_statement (annual, 2024-12-31) — Other Gand A: 1172162.00
MYSE income_statement (annual, 2024-12-31) — Other Income Expense: -12858.00
MYSE income_statement (quarterly, 2024-12-31) — Other Income Expense: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1050000.00
MYSE balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1050000.00
MYSE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 166560.00
MYSE cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -12616.00
MYSE balance_sheet (annual, 2024-12-31) — Other Properties: 33436.00
MYSE balance_sheet (quarterly, 2024-12-31) — Other Properties: 33436.00
MYSE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 2952512.00
MYSE balance_sheet (annual, 2024-12-31) — Payables: 603378.00
MYSE balance_sheet (quarterly, 2024-12-31) — Payables: 603378.00
MYSE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 603378.00
MYSE balance_sheet (annual, 2024-12-31) — Preferred Stock: 200.00
MYSE balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 200.00
MYSE balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 200.00
MYSE cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 121648.00
MYSE income_statement (annual, 2024-12-31) — Pretax Income: -2948415.00
MYSE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 861522.00
MYSE cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Properties: 0.00
MYSE cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
MYSE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -10767288.00
MYSE cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Receivables: 207.00
MYSE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1794611.00
MYSE income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 438445.00
MYSE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 97106.00
MYSE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
MYSE income_statement (annual, 2024-12-31) — Research And Development: 166667.00
MYSE income_statement (quarterly, 2024-12-31) — Research And Development: 34220.00
MYSE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
MYSE income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Retained Earnings: -52373248.00
MYSE income_statement (annual, 2024-12-31) — Salaries And Wages: 1794611.00
MYSE cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
MYSE cash_flow (annual, 2024-12-31) — Sale Of Investment: 13004039.00
MYSE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 84163.00
MYSE income_statement (annual, 2024-12-31) — Selling General And Administration: 3050936.00
MYSE balance_sheet (annual, 2024-12-31) — Share Issued: 3076274.00
MYSE cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
MYSE income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
MYSE income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
MYSE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 145800.00
MYSE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6878936.00
MYSE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5828736.00
MYSE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MYSE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Total Assets: 5371458.00
MYSE balance_sheet (annual, 2024-12-31) — Total Capitalization: 6878936.00
MYSE balance_sheet (annual, 2024-12-31) — Total Debt: 0.00
MYSE balance_sheet (quarterly, 2024-12-31) — Total Debt: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4741147.00
MYSE income_statement (annual, 2024-12-31) — Total Expenses: 3217603.00
MYSE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 630311.00
MYSE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1083436.00
MYSE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MYSE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3217167.00
MYSE income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
MYSE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 66945.00
MYSE balance_sheet (annual, 2024-12-31) — Treasury Stock: 397969.00
MYSE cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
MYSE cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
MYSE balance_sheet (annual, 2024-12-31) — Working Capital: 3657711.00
MYSE income_statement (quarterly, 2025-03-31) — +Operating Expense: 1434044.00
MYSE income_statement (quarterly, 2025-03-31) — +Total Revenue: 83.00
MYSE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 247.00
MYSE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -72620.00
MYSE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 64525389.00
MYSE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4089329.00
MYSE income_statement (quarterly, 2025-03-31) — Basic EPS: -0.36
MYSE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 766985.00
MYSE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -72625.00
MYSE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -72625.00
MYSE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 628.00
MYSE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1265478.00
MYSE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 7050697.00
MYSE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4379500.00
MYSE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -2905332.00
MYSE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1190485.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4361.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 294365.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Payable: -4361.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4361.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -21934.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -40.00
MYSE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 268030.00
MYSE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -40.00
MYSE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 283683.00
MYSE balance_sheet (quarterly, 2025-03-31) — Common Stock: 428.00
MYSE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10281404.00
MYSE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 4532000.00
MYSE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 967280.00
MYSE balance_sheet (quarterly, 2025-03-31) — Current Assets: 7205507.00
MYSE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 121.00
MYSE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 121.00
MYSE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 699436.00
MYSE cash_flow (quarterly, 2025-03-31) — Depreciation: 5541.00
MYSE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5541.00
MYSE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5541.00
MYSE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4089329.00
MYSE income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.36
MYSE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1473196.00
MYSE income_statement (quarterly, 2025-03-31) — EBIT: -1433961.00
MYSE income_statement (quarterly, 2025-03-31) — EBITDA: -1428420.00
MYSE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
MYSE cash_flow (quarterly, 2025-03-31) — End Cash Position: 1050668.00
MYSE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4379500.00
MYSE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1263110.00
MYSE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 0.00
MYSE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1400207.00
MYSE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1122625.00
MYSE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 100515.00
MYSE income_statement (quarterly, 2025-03-31) — Gross Profit: -967197.00
MYSE cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
MYSE income_statement (quarterly, 2025-03-31) — Interest Income: 41336.00
MYSE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 41336.00
MYSE cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 2831.00
MYSE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 10281404.00
MYSE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -2905332.00
MYSE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 4532000.00
MYSE balance_sheet (quarterly, 2025-03-31) — Leases: 4350.00
MYSE balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 96165.00
MYSE balance_sheet (quarterly, 2025-03-31) — Minority Interest: -2472513.00
MYSE income_statement (quarterly, 2025-03-31) — Minority Interests: 145914.00
MYSE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 4532000.00
MYSE cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income: -1473196.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1473196.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1392625.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -226485.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1473196.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1246711.00
MYSE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1619110.00
MYSE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1619110.00
MYSE income_statement (quarterly, 2025-03-31) — Net Interest Income: 41336.00
MYSE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -2832707.00
MYSE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 41336.00
MYSE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -152500.00
MYSE balance_sheet (quarterly, 2025-03-31) — Net PPE: 27895.00
MYSE cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
MYSE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 9158979.00
MYSE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 152500.00
MYSE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1428420.00
MYSE income_statement (quarterly, 2025-03-31) — Normalized Income: -1246711.00
MYSE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1190485.00
MYSE income_statement (quarterly, 2025-03-31) — Operating Income: -1433961.00
MYSE income_statement (quarterly, 2025-03-31) — Operating Revenue: 83.00
MYSE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4209329.00
MYSE income_statement (quarterly, 2025-03-31) — Other Gand A: 484045.00
MYSE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1122625.00
MYSE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 5785219.00
MYSE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 699315.00
MYSE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 200.00
MYSE balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 200.00
MYSE cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 0.00
MYSE balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 154563.00
MYSE income_statement (quarterly, 2025-03-31) — Pretax Income: -1392625.00
MYSE balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MYSE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -4314310.00
MYSE balance_sheet (quarterly, 2025-03-31) — Receivables: 247.00
MYSE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 967280.00
MYSE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5541.00
MYSE income_statement (quarterly, 2025-03-31) — Research And Development: 6000.00
MYSE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -53846444.00
MYSE income_statement (quarterly, 2025-03-31) — Salaries And Wages: 916162.00
MYSE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 1481603.00
MYSE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 33837.00
MYSE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1434044.00
MYSE balance_sheet (quarterly, 2025-03-31) — Share Issued: 4276274.00
MYSE income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MYSE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 155054.00
MYSE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10281604.00
MYSE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 9158779.00
MYSE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MYSE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
MYSE balance_sheet (quarterly, 2025-03-31) — Total Assets: 8508527.00
MYSE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10281604.00
MYSE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 7809091.00
MYSE income_statement (quarterly, 2025-03-31) — Total Expenses: 1434044.00
MYSE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 699436.00
MYSE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1303020.00
MYSE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MYSE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1433961.00
MYSE income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MYSE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MYSE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 66945.00
MYSE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 397969.00
MYSE cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
MYSE balance_sheet (quarterly, 2025-03-31) — Working Capital: 6506071.00
MYSE income_statement (quarterly, 2025-06-30) — +Operating Expense: 1406906.00
MYSE income_statement (quarterly, 2025-06-30) — +Total Revenue: 78.00
MYSE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 597651.00
MYSE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 220.00
MYSE balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -10318.00
MYSE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 64676721.00
MYSE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4209329.00
MYSE income_statement (quarterly, 2025-06-30) — Basic EPS: -0.29
MYSE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1050668.00
MYSE balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 244793.00
MYSE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -106491.00
MYSE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -102016.00
MYSE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 241231.00
MYSE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 628.00
MYSE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 407888.00
MYSE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 5714589.00
MYSE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -24028.00
MYSE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 372027.00
MYSE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1420493.00
MYSE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -3562.00
MYSE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -294348.00
MYSE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -28211.00
MYSE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 88192.00
MYSE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 27.00
MYSE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -237902.00
MYSE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 27.00
MYSE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1072494.00
MYSE balance_sheet (quarterly, 2025-06-30) — Common Stock: 428.00
MYSE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 9215864.00
MYSE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
MYSE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 679107.00
MYSE balance_sheet (quarterly, 2025-06-30) — Current Assets: 5787155.00
MYSE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 46502.00
MYSE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 46502.00
MYSE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 105.00
MYSE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 105.00
MYSE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 644258.00
MYSE cash_flow (quarterly, 2025-06-30) — Depreciation: 15986.00
MYSE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 15986.00
MYSE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 15986.00
MYSE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4209329.00
MYSE income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.29
MYSE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1216872.00
MYSE income_statement (quarterly, 2025-06-30) — EBIT: -1406828.00
MYSE income_statement (quarterly, 2025-06-30) — EBITDA: -1390842.00
MYSE cash_flow (quarterly, 2025-06-30) — End Cash Position: 407888.00
MYSE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -24028.00
MYSE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1526984.00
MYSE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
MYSE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1329665.00
MYSE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1224641.00
MYSE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 271495.00
MYSE income_statement (quarterly, 2025-06-30) — Gross Profit: -679029.00
MYSE cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
MYSE income_statement (quarterly, 2025-06-30) — Interest Income: 49639.00
MYSE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 49639.00
MYSE cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 1419.00
MYSE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 9215864.00
MYSE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 372027.00
MYSE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
MYSE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 194729.00
MYSE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 194729.00
MYSE balance_sheet (quarterly, 2025-06-30) — Minority Interest: -2605550.00
MYSE income_statement (quarterly, 2025-06-30) — Minority Interests: 140317.00
MYSE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
MYSE cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 0.00
MYSE income_statement (quarterly, 2025-06-30) — Net Income: -1216872.00
MYSE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1216872.00
MYSE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1357189.00
MYSE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1216872.00
MYSE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1216872.00
MYSE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1357189.00
MYSE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1357189.00
MYSE income_statement (quarterly, 2025-06-30) — Net Interest Income: 49639.00
MYSE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 478518.00
MYSE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 49639.00
MYSE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -24028.00
MYSE balance_sheet (quarterly, 2025-06-30) — Net PPE: 261177.00
MYSE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 7991423.00
MYSE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 176528.00
MYSE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1390842.00
MYSE income_statement (quarterly, 2025-06-30) — Normalized Income: -1216872.00
MYSE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1420493.00
MYSE income_statement (quarterly, 2025-06-30) — Operating Income: -1406828.00
MYSE income_statement (quarterly, 2025-06-30) — Operating Revenue: 78.00
MYSE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4209329.00
MYSE income_statement (quarterly, 2025-06-30) — Other Gand A: 650558.00
MYSE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1224641.00
MYSE balance_sheet (quarterly, 2025-06-30) — Other Properties: 26702.00
MYSE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 5306701.00
MYSE balance_sheet (quarterly, 2025-06-30) — Payables: 597651.00
MYSE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 597651.00
MYSE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 200.00
MYSE balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 200.00
MYSE balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 72346.00
MYSE income_statement (quarterly, 2025-06-30) — Pretax Income: -1357189.00
MYSE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
MYSE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1003425.00
MYSE balance_sheet (quarterly, 2025-06-30) — Receivables: 220.00
MYSE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 679107.00
MYSE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 15986.00
MYSE income_statement (quarterly, 2025-06-30) — Research And Development: 5000.00
MYSE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -55063316.00
MYSE income_statement (quarterly, 2025-06-30) — Salaries And Wages: 679107.00
MYSE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1481943.00
MYSE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 72241.00
MYSE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1401906.00
MYSE balance_sheet (quarterly, 2025-06-30) — Share Issued: 4276274.00
MYSE income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
MYSE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 158612.00
MYSE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 9216064.00
MYSE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 7991223.00
MYSE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MYSE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Assets: 7449501.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 9216064.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Debt: 241231.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6610514.00
MYSE income_statement (quarterly, 2025-06-30) — Total Expenses: 1406906.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 838987.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1662346.00
MYSE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 194729.00
MYSE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1406828.00
MYSE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
MYSE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
MYSE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 66945.00
MYSE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 397969.00
MYSE balance_sheet (quarterly, 2025-06-30) — Working Capital: 5142897.00
MYSE income_statement (quarterly, 2025-09-30) — +Operating Expense: 1280929.00
MYSE income_statement (quarterly, 2025-09-30) — +Total Revenue: 328.00
MYSE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 798922.00
MYSE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 224.00
MYSE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -21760.00
MYSE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 64999536.00
MYSE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 4221883.00
MYSE income_statement (quarterly, 2025-09-30) — Basic EPS: -0.28
MYSE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 407888.00
MYSE balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 244793.00
MYSE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16197.00
MYSE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -16197.00
MYSE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 230297.00
MYSE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 633.00
MYSE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 457626.00
MYSE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4803936.00
MYSE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 10000.00
MYSE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 944194.00
MYSE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -904456.00
MYSE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -10934.00
MYSE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -42.00
MYSE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 201271.00
MYSE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -105903.00
MYSE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4.00
MYSE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 84388.00
MYSE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -4.00
MYSE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 49738.00
MYSE balance_sheet (quarterly, 2025-09-30) — Common Stock: 433.00
MYSE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 8337207.00
MYSE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
MYSE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 775965.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Assets: 5081033.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 48732.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Debt: 40000.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 88732.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 63.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 63.00
MYSE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 887717.00
MYSE cash_flow (quarterly, 2025-09-30) — Depreciation: 25721.00
MYSE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 25721.00
MYSE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 25721.00
MYSE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 4221883.00
MYSE income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.28
MYSE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1201477.00
MYSE income_statement (quarterly, 2025-09-30) — EBIT: -1280601.00
MYSE income_statement (quarterly, 2025-09-30) — EBITDA: -1254880.00
MYSE cash_flow (quarterly, 2025-09-30) — End Cash Position: 457626.00
MYSE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 10000.00
MYSE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -920653.00
MYSE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
MYSE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1226842.00
MYSE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1231626.00
MYSE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 266428.00
MYSE income_statement (quarterly, 2025-09-30) — Gross Profit: -775637.00
MYSE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
MYSE income_statement (quarterly, 2025-09-30) — Interest Income: 49120.00
MYSE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 49120.00
MYSE cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 3160.00
MYSE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8377207.00
MYSE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 944194.00
MYSE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
MYSE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 181565.00
MYSE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 181565.00
MYSE balance_sheet (quarterly, 2025-09-30) — Minority Interest: -2642834.00
MYSE income_statement (quarterly, 2025-09-30) — Minority Interests: 30004.00
MYSE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
MYSE cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 0.00
MYSE income_statement (quarterly, 2025-09-30) — Net Income: -1201477.00
MYSE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1201477.00
MYSE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1231481.00
MYSE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1201477.00
MYSE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1201477.00
MYSE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1231481.00
MYSE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1231481.00
MYSE income_statement (quarterly, 2025-09-30) — Net Interest Income: 49120.00
MYSE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 960391.00
MYSE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 49120.00
MYSE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -30000.00
MYSE balance_sheet (quarterly, 2025-09-30) — Net PPE: 244668.00
MYSE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
MYSE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 7105781.00
MYSE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 206528.00
MYSE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1254880.00
MYSE income_statement (quarterly, 2025-09-30) — Normalized Income: -1201477.00
MYSE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -904456.00
MYSE income_statement (quarterly, 2025-09-30) — Operating Income: -1280601.00
MYSE income_statement (quarterly, 2025-09-30) — Operating Revenue: 328.00
MYSE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4264329.00
MYSE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 40000.00
MYSE income_statement (quarterly, 2025-09-30) — Other Gand A: 450877.00
MYSE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1231626.00
MYSE balance_sheet (quarterly, 2025-09-30) — Other Properties: 21635.00
MYSE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 4346310.00
MYSE balance_sheet (quarterly, 2025-09-30) — Payables: 798922.00
MYSE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 798922.00
MYSE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 200.00
MYSE balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 200.00
MYSE balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 276873.00
MYSE income_statement (quarterly, 2025-09-30) — Pretax Income: -1231481.00
MYSE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
MYSE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
MYSE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -506435.00
MYSE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
MYSE balance_sheet (quarterly, 2025-09-30) — Receivables: 224.00
MYSE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 775965.00
MYSE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 25721.00
MYSE income_statement (quarterly, 2025-09-30) — Research And Development: 0.00